(S) -CCG-1423
(S) -CCG-1423 is the stereoisomeric form of the Rho signaling inhibitor CCG-1423. It functions by inhibiting the myocardin-related transcription factor A (MRTF-A) /serum response factor (SRF) pathway. This compound is utilized in cardiovascular and cancer research, demonstrating activity in both cellular and animal models of fibrosis and metastasis.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Smiles
O=C (NO[C@@H] (C) C (NC1=CC=C (Cl) C=C1) =O) C2=CC (C (F) (F) F) =CC (C (F) (F) F) =C2
Molecular Formula
C18H13ClF6N2O3
Molecular Weight
454.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2099-99G-PE 100 µL
CCR5 (Chemokine (C-C motif) Receptor 5, C-C Chemokine Receptor Type 5, CCCKR5, CC-CKR-5, C-C CKR-5, CCR-5, AM4-7, CD195, CHEMR13, CKR5, CMKBR5, FLJ78003, HIV-1 Fusion Coreceptor, IDDM22) (PE) discontinued
Sign In for Pricing
View Details ![6- (4-Methoxyphenyl) -3H,4H-thieno[3,2-d]pyrimidin-4-one](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
AJA38522-01 0.5 g
6- (4-Methoxyphenyl) -3H,4H-thieno[3,2-d]pyrimidin-4-one
Sign In for Pricing
View Details AJA38522-02 5 g
6- (4-Methoxyphenyl) -3H,4H-thieno[3,2-d]pyrimidin-4-one
Sign In for Pricing
View Details